There is a strong wealth destruction current under the calm and small caps are bearing a brunt of that
India’s equity market appears untroubled. Benchmark indices have held their range, heavyweight stocks continue to attract steady flows. To the casual observer, it looks like a market taking a breather.
That impression, however, is misleading.
Beneath the calm, a growing number of stocks—mostly in the small- and mid-cap segment—have undergone sharp and prolonged corrections. The damage is not visible in the indices, but it is very real for investors who bought into high-valuation stocks during the last phase of exuberance.
When the Index Lies to You
Headline indices are doing what they are designed to do: reflect the performance of a narrow group of large, liquid companies. Those stocks have largely held up, masking what is happening elsewhere.
In the broader market, particularly among stocks that were priced for rapid growth, the adjustment has been unforgiving. Many of these companies are now trading 60% to 90% below their peak levels, despite no single event marking the turn.
For investors whose portfolios were tilted heavily toward smaller names, the experience has been starkly different from what the index suggests.
From Euphoria to Free Fall
During the rally, a wide range of stocks traded at valuations that assumed flawless execution and sustained high growth. Engineering services, logistics, specialty manufacturing, niche technology and pharma names were among the most aggressively re-rated.
Recent market data circulating among investors shows how sharply sentiment has turned. Stocks such as Gensol Engineering, Vishnu Prakash R Punglia, Trident Techlabs and Allcargo Logistics have seen deep drawdowns from their highs. So have companies like DCM Shriram Industries, Dreamfolks Services, Tejas Networks, Quick Heal Technologies and Genesys International.
Others—including Revathi Equipment, Cohance Lifesciences, Themis Medicare, JNK India, Salzer Electronics and Chemfab Alkalis—tell similar stories. Across this group, losses range from roughly 60% to nearly 97% from peak levels.
The declines have not been sudden. They have unfolded gradually, as earnings failed to catch up with expectations and valuations lost support.
Calm Markets, Violent Repricing
What makes this phase deceptive is the absence of panic. There has been no broad sell-off, no sharp spike in volatility and no dramatic breakdown in the indices.
Instead, the market has been quietly repricing risk. Capital has moved toward companies with size, balance-sheet strength and predictable cash flows. Stocks that depended on optimism and liquidity to sustain high multiples have struggled to find buyers.
This is how excesses are usually unwound—not all at once, but steadily.
Momentum Is Temporary. Valuations Are Not
Many of the hardest-hit stocks shared common characteristics at their peaks: strong recent price performance, optimistic growth assumptions and valuations that left little margin for disappointment.
When conditions tightened—whether through slower demand, execution delays or more cautious capital flows—the market adjusted expectations. Prices followed.
The process has been mechanical rather than emotional, and that may be why it has gone largely unnoticed.
Lessons the Market Is Repeating
The episode reinforces a few familiar truths.
Index stability does not guarantee portfolio safety. Valuation discipline matters, even during strong market phases. And small-cap investing, while rewarding over time, can be unforgiving when optimism outruns fundamentals.
